Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.92 USD | +1.47% | -6.74% | -9.85% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Financials (USD)
Sales 2024 * | 535M | Sales 2025 * | 579M | Capitalization | 736M |
---|---|---|---|---|---|
Net income 2024 * | 43M | Net income 2025 * | 57M | EV / Sales 2024 * | 1.62 x |
Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.41 x |
P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
13.2
x | Employees | 3,500 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.25% | Free-Float | 98.99% |
Latest transcript on Core Laboratories Inc.
1 day | +1.47% | ||
1 week | -6.74% | ||
Current month | +0.76% | ||
1 month | -8.14% | ||
3 months | +7.35% | ||
6 months | -25.08% | ||
Current year | -9.85% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 15.92 | +1.40% | 210,404 |
24-05-02 | 15.7 | -0.06% | 317,490 |
24-05-01 | 15.71 | -0.57% | 297,583 |
24-04-30 | 15.8 | -6.78% | 418,318 |
24-04-29 | 16.95 | +0.06% | 311,089 |
Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.85% | 736M | |
+13.54% | 16.86B | |
0.00% | 7.03B | |
-11.41% | 2.91B | |
-6.89% | 2.85B | |
-27.64% | 1.83B | |
-2.47% | 1.16B | |
-6.63% | 1.07B | |
-10.95% | 831M | |
+0.83% | 761M |
- Stock Market
- Equities
- CLB Stock